Strengthening of the Medicines and Medical Devices Agency of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity
Project Description
The overall objective of the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity” is full and correct implementation of the EU acquis in the area of medicinal products and medical devices and preparation of the Medicines and Medical Devices Agency of the Republic of Moldova for joining the EU regulatory agencies network as an equal partner.
The main purpose this EU-funded project is to strengthen the functioning of the MMDA with regards to medicinal products manufacturing, marketing, pharmacovigilance, distribution and pricing and medical devices in scope of market supervision, vigilance and registration as well as to clinical trials and pharmaceutical activity.
The completion of this EU-funded Project should deliver the MMDA with capacities at the same level as peer institutions in the EU Member States and should allow patients to benefit from safer, better quality and more effective medicinal products and medical devices.
The main purpose this EU-funded project is to strengthen the functioning of the MMDA with regards to medicinal products manufacturing, marketing, pharmacovigilance, distribution and pricing and medical devices in scope of market supervision, vigilance and registration as well as to clinical trials and pharmaceutical activity.
The completion of this EU-funded Project should deliver the MMDA with capacities at the same level as peer institutions in the EU Member States and should allow patients to benefit from safer, better quality and more effective medicinal products and medical devices.
Specific Objective
The main purpose this EU-funded project is to strengthen the functioning of the MMDA with regards to medicinal products manufacturing, marketing, pharmacovigilance, distribution and pricing and medical devices in scope of market supervision, vigilance and registration as well as to clinical trials and pharmaceutical activity.
The completion of this EU-funded Project should deliver the MMDA with capacities at the same level as peer institutions in the EU Member States and should allow patients to benefit from safer, better quality and more effective medicinal products and medical devices.
The completion of this EU-funded Project should deliver the MMDA with capacities at the same level as peer institutions in the EU Member States and should allow patients to benefit from safer, better quality and more effective medicinal products and medical devices.
Expected Results
- Approximation of the legal framework and strengthening of MMDA’s institutional and organisational capacities.
- Strengthening of MMDA’s regulatory functioning with respect to medicinal products.
- Strengthening of MMDA’s regulatory functioning with respect to medical devices.
- Improvement of rational use of medicines and medical devices in Moldova.
- Transition of MMDA to full compliance with the EU requirements.
- Strengthening of MMDA’s regulatory functioning with respect to medicinal products.
- Strengthening of MMDA’s regulatory functioning with respect to medical devices.
- Improvement of rational use of medicines and medical devices in Moldova.
- Transition of MMDA to full compliance with the EU requirements.
Project map
Photo gallery
PROJECT DETAILS
Moldova
Priority Area:
Partnership that greens Subsector:
Health Topic:
Health Project Status:
Completed Start Date:
11.01.2017 End Date:
10.03.2019 Website:
http://amed.md/en/content/twinning-0
EU Project Number:
379-970